Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (241-250 of 493) with videos related to

Pageof 50
Sort By:
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Joint Bone Spine|November 16, 2024
Intestinal barrier biomarkers in adult patients with juvenile idiopathic arthritis in transitionSophie Hecquet, Marion Thomas, Eleonore Parisel, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Annals of the Rheumatic Diseases|February 26, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosisMatthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, et al.
Annals of the Rheumatic Diseases|June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR modelWanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Scientific Reports|September 5, 2023
Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatmentJérôme Avouac, Eloïse Vandebeuque, Alice Combier, et al.
Arthritis Research & Therapy|November 30, 2013
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesisMirko Manetti, Serena Guiducci, Eloisa Romano, et al.
Pageof 50

Showing results (241-250 of 493) with videos related to

Sort By:
Pageof 50
The Lancet. Rheumatology|January 26, 2024
Digital ulcers: should debridement be a standard of care in systemic sclerosis?Michael Hughes, Begonya Alcacer-Pitarch, Yannick Allanore, et al.
Rheumatology (Oxford, England)|June 9, 2023
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung diseaseYannick Allanore, Dinesh Khanna, Vanessa Smith, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Joint Bone Spine|November 16, 2024
Intestinal barrier biomarkers in adult patients with juvenile idiopathic arthritis in transitionSophie Hecquet, Marion Thomas, Eleonore Parisel, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Annals of the Rheumatic Diseases|February 26, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosisMatthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, et al.
Annals of the Rheumatic Diseases|June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR modelWanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Scientific Reports|September 5, 2023
Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatmentJérôme Avouac, Eloïse Vandebeuque, Alice Combier, et al.
Arthritis Research & Therapy|November 30, 2013
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesisMirko Manetti, Serena Guiducci, Eloisa Romano, et al.
Pageof 50